Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1971-10-14
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0035-3787
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
123
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
297-319
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:5513630-Adult,
pubmed-meshheading:5513630-Aged,
pubmed-meshheading:5513630-Dihydroxyphenylalanine,
pubmed-meshheading:5513630-Dopa Decarboxylase,
pubmed-meshheading:5513630-Drug Synergism,
pubmed-meshheading:5513630-Humans,
pubmed-meshheading:5513630-Middle Aged,
pubmed-meshheading:5513630-Parkinson Disease,
pubmed-meshheading:5513630-Time Factors
|
| pubmed:year |
1970
|
| pubmed:articleTitle |
[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
|
| pubmed:publicationType |
Journal Article
|